Purpose: Comparative genomic hybridization (CGH) is a powerful DNA-based cytogenetic technique that allows the entire genome to be scanned for chromosomal imbalances without requiring the sample material to be mitotically active. During the past 2 years we received many requests from various medical centers around the country to use CGH to resolve the identity of aberrant chromosomal material. Methods 
I M U C T I O N
Approximately 3% to 4% of liveborn babies have a major congenital defect.' These defects include unbalanced chromosome abnormalities which occur in approximately 1 in 250 newborm2 Between 15% and 20% of all pregnancies end in a spontaneous abortion, and of these approximately 50% are associated with chromosome abn~rmalities.~ A precise diagnosis in a newborn or prenatal sample with a chromosome abnormality is critical for appropriate genetic counseling as well as for the clinical management of an infant. It also provides the parents with a realistic prognosis. There are many instances when cytogenetic analysis is unsuccessful in producing a result because the specimen cannot be cultured. There are also many occasions when extrachromosomal material remains unidentifiable even after numerous standard cytogenetic staining methods have been attempted. Molecular cytogenetic techniques, such as fluorescence in situ hybridization (FISH), have brought a new depth to clinical cytogenetics by facilitating the identification of chromosomal material of unknown origin. This approach often requires using multiple whole chromosome paints (WCP) until the source chromosome is identified.s5 Alternative approaches include reverse FISH, using probes derived from the microdissected chromosome region of interestM; and multicolor FISH p r~b i n g .~. 'O However, these techniques require specialized equipment in addition to the regular cytogenetic/FISH image analysis equipment that now is commonly found in many comprehensive cytogenetic laboratories. Although multicolor FISH can determine the origin of the unknown material, it does not identify the specific location or breakpoints on the chromosome from which the extra material originated.
Comparative genomic hybridization (CGH) is a relatively new molecular cytogenetic technique that allows for the identification of chromosomal gains or losses by scanning the entire genome in a single step. It has the distinct advantage of providing a genome-wide search without any prior &formation about the chromosomal aberration in question. It is accomplished by in situ hybridization of differentially labeled total genornic specimen DNA and normal reference DNA to normal human metaphase chromosome ~preads.'l-~~ Hybridization of the specimen and reference DNA can be distinguished by their Merent fluorescent colors. The relative amounts of specimen and reference DNA hybridized at a particular chromosome position are contingent on the relative excess of those sequences in the two DNA samples and can be quantified by calculation of the ratio of their different fluorescent c~l o r s .~~-l~ Specimen DNA is traditionally labeled with a green fluorochrome such as fluorescein isothiocyanate and the normal reference DNA with a red fluorochrome like Texas Red. A gain of chromosomal material in a specimen would be detected by an elevated greento-red ratio, whereas deletions or chromosomal losse~ would produce a reduced green-to-red ratio."-" CGH analysis provides information about the origin of gains and losses of chromosomal material and maps these imbalances to their position on the source Comparative genomic hybridization CGH was performed according to the method of Kallioniemi et al.,I4 with the following modifications. DNA from peripheral blood lymphocytes of each patient and a karyotypically normal control (sex matched to the patient) was isolated by standard techniques.13 Reference and sample DNA were labeled by nick translation with Texas Red-5-deoxyuridine triphosphate (dUTP) and fluorescein-12-dUTP (DuPont NEN, Boston, MA), respectively. The hybridization mixture consisted of 200 ng specimen DNA, 200 ng reference DNA, and 20 pg Cot-1 DNA (GIBCOIBRL, Gaithersburg, MD) in 10 pL of Hybrisol VII (Oncor, Gaithersburg, MD). The probe mixture was hybridized to normal male metaphase spreads (46,XY) for 3 days at 37OC. Unbound DNA f;agments were removed by washing in 2 X saline sodium citrate (SSC) at 72OC for 5 minutes, 4X SSC at 37°C for 5 minutes, 4X SSC, 0.1% Triton X at 37°C for 5 minutes, 4X SSC at 37OC for 5 minutes, 2X SSC at room temperature for 5 minutes, and in H,O at room temperature for 5 minutes.
CGH images were captured with an Imagepoint cooled CCD video camera (Photometrics, Tucson, AZ) through a Labophot-2A fluorescence microscope (Nikon, Melville, NY). Chromosome identification and karyotyping was facilitated by counterstaining with 0.1 pg/pL 4,6-diamidino-2-phen@dole (DAPI) in Vectashield (Vector Laboratories, Burlingame, CA)?4 Metaphases with relatively straight nonoverlapping chromosomes were analyzed. The fluorescence ratios (greenlred) for at least 10 of each autosome and 7 of each sex chromosome were obtained per slide. Background fluorescence was subtracted, and the green-to-red ratio of each entire metaphase was normalized to 1.0. Data from several metaphase spreads were combined to generate an average ratio profile for each chromosome. The lines in the CGH profiles ( Fig. 1: column B) represent ratios of (from left to right) 0.5,0.75,1.0,1.25, 1.5, 1.75, and 2.0. A ratio of 1.0 represents the balanced state of the chromosomal copy number. An upper threshold of > 1.20 was used to define a gain of chromosomal material, whereas a lower threshold of <0.80 was used to interpret a loss (deletion) of chromosomal material?5 Gains and losses were only considered relevant if the 95% confidence intervals (data not shown), derived from the combination of each single chromosome profile, met the threshold criteria. Digital image analysis was performed with a Cytovision Probe system and CGH software (Applied Imaging Corp, Santa Clara, CA).
fluorescence in situ hybtidiion
Whole chromosome paints were purchased either from Vysis (Downers Grove, IL) or from Oncor (Gaithersburg, MD). Chromosome arm-specific paints were purchased kom ALTechnologies (Arling: ton, VA), and locus-specific probes were obtained from Oncor (Gaithersburg, MD). FISH studies were performed according to the manufacturer's instructions. Metaphase spreads were counterstained with Indianapolis, IN) . The hybridization mixture consisted of 150 ng DNA of each probe, 4 pg Cot-1 DNA, and 7 kg herring sperm DNA (GIBCOIBRL, Gaithersburg, MD) in 10 pL of Hybrisol VII (Oncor, Gaithersburg, MD). The probe mixture was hybridized overnight in a humid chamber at 37OC to metaphase spreads derived from the patient in case 12. Unbound DNA fragments were removed by washing in 2X SSC at 72OC for 5 minutes and 1 X phosphate-buffered detergent (PBD) for 3 minutes at room temperature. Slides were then incubated with 60 pL Avidin-FTCI antidigo~genin-rhodamine (Oncor, Gaithersburg, MD) for 15 minutes at 37OC. This was followed by three 3-minute washes in 1 X PBD at room temperature. Metaphase spreads were counterstained with 0.1 pg/pL DAPI invectashield (Vector Laboratories, Burlingame, CA).24 FISH images were captured as described in the CGH section.
RESULTS
From October 1996 to April 1998, CGH analysis was performed on seven postnatal clinical samples received from six different medical centers around the country. Five additional samples were referred from our own institution. All samples were derived from patients in whom traditional cytogenetic analyses revealed extrachromosomal material of unknown origin. In all instances, CGH analysis accurately identified the derivation of the aberrant chromosome. All CGH findings were confirmed either by FISH or DA-DAPI staining. A summary of the results of the comprehensive workup of each patient is shown in Table 1 . Figure 1 shows the cytogenetic aberrations in question (column A), the CGH ratio profiles (column B), and the confirmation of the CGH results (column C). CGH results are displayed with representative chromosome profiles. All other chromosomes (data not shown) had normal CGH profiles, with no significant deviation from a value of 1.0.
The first five cases demonstrate the effective use of CGH in resolving the identity of marker chromosomes. The sizes of the markers varied considerably ( Fig. 1: 1A-5A ). The markers that were derived from chromosome 15 probably were formed by an inversion duplication event in cases 1,2, and possibly in case 3, as judged by their G-bands by trypsin using Giemsa (GTG) pattern. Concurrent molecular and molecular-cytogenetic study by the referring institution of the patient in case 3 did not demonstrate the presence of the Prader-Willi probes (SNRPN and D15S11) in the marker chromosome but revealed uniparental maternal heterodisomy of chromosome 15. The clinical features presenting in this patient are therefore considered to result from an initial trisomy 15 event with subsequent loss of the majority of the paternal 15 chromosome leaving two maternal chromosomes 15 and a paternally derived marker chromosome 15.
The marker in case 4 showed an overrepresentation of the entire short arm of chromosome 18 ( Fig.  1: 4B) . Together with the cytogenetic appearance ( Fig. 1: 4A) , this marker was determined to be an 18p isochromosome. In case 5, an overrepresentation of patient DNA at the centromeric region of chromosome 1 ( Fig. 1 : 5B) was considered to be a significant and real finding compared with the frequently observed increase in this region which is primarily a result of the repetitive nature of the heterochromatic DNA. A comparison of the chromosome 1 ratio profile in cases 5 and 10 ( Fig. 1 : 5B vs. 10B) reveals an upward shift into the short arm in case 5 when matched with the insignificant pattern in case 10. The extrachromosomal material therefore derives from proximal l p and includes some of the heterochromatic region of proximal 1q.
Translocations
The designation of the source of the additional material in cases 6 to 10 was achieved easily by CGH. These five cases represent unbalanced translocations. The translocations in cases 6,8, and 10 were de novo in nature because cytogenetic analyses of the parents revealed normal karyotypes. Chromosome analysis of the mother in case 7 revealed a normal karyotype; the father was not available for cytogenetic studies. In case 9, chromosome analysis of the parents, after the CGH studies, revealed that the mother carried a balanced XI19 translocation. Dual color FISH in cases 6 to 9 readily confirmed the origins of the additional material in the unbalanced chromosome ( Fig. 1: C6-C9) . In addition to a gain of chromosome 19q material in case 9, a loss in the short arm of the X chromosome is also evident from the CGH profile ( Fig. 1: 9B ). This loss is also discernible from the GTG image ( Fig. 1: 9A) . The deletion of the distal area of Xp in case 9 was confirmed using a locus-specific probe (STS gene probe) which showed no signal on the derivative X chromosome ( Fig. 1: 9C) . In case 10, the CGH profile indicated that the short arm of chromosome 17 was the source of the additional material on the 2 1p + chromosome.
Verification was obtained by FISH using a chromosome 17 WCP and a locus-specific probe (MillerDieker gene probe) for the short arm of chromosome 17. Both showed a signal on derivative chromosome 2 1 as well as on the two normal chromosomes 17. The apparent overrepresentation of the distal region of 17q ( Fig. 1: 10B ) in case 10 was not significant at the 95% confidence interval level. as determined bv the confidence intervals by combining thi CGH ratios from 18 representatives of chromosome 17 (data not shown).
lntrachrwnosomal duplications
The final two cases represent examples of the utility of CGH in identifying and elucidating intrachromosomal duplications. In case 11, the CGH ratio profile for chromosome 16, indicating a gain of material ( Fig. 1: 1 lB) , is distinctly different from the inconsequential gain expected for the heterochromatic region of chromosome 16 ( Fig. 1: 10B vs. 11B). Using dual color arm specific paints for chromosome 16 clearly shows the insertion of 16q material into the short arm of chromosome 16 ( Fig.  1: 11C) . The orientation of the insertion (q12.1-q22.1) seems to be inverted from the GTG appearance; however, further molecular cytogenetic analysis Genetjcs w Medicine is needed for verification. In case 12 ( Fig. 1: 12B) , an intrachromosomal duplication involving the long arm of chromosome 13 clearly can be inferred from the CGH profile. The duplication was confirmed using probes specific for bands 13q3 1 (BAC 13C5), 13q32 (BAC 13C7), and 13q32133 (BAC 13Cll) which showed one signal for BAC 13C5 and two signals each for BACs 13C7 and 13Cll ( Fig. 1: 12C) . The observation of only one signal for BAC 13C5 indicates that the duplication event is confined to a region of 13q3 1 that is distal to BAC 13C5. The orientation of the duplication was delineated as an inversion duplication using dual color FISH with BACs 13C5/13C7 (data not shown); 13C5/13Cll and 13C7/ 13C11 which showed signals in the order of (proximal to distal) BAC 13C5, BAC 13C7, BAC 13C11, BAC 13C11, BAC 13C7 ( Fig. 1:12C) .
DISCUSSION
The rapid advance of molecular cytogenetic technology has led to an increased number of referrals of specimens to specialized laboratories from patients with complex and unresolvable G-banded karyotypes. In clinical cytogenetics, the precise identification of the origin of the additional or missing chromosomal material is a key factor when considering genotype-phenotype correlations and ultimately may lead to the discovery of the genes responsible for the clinical abnormalities that present in such patients. Defining the origin of unknown additional cytogenetic material with FISH by use of various probes is expensive and laborious because many whole chromosome paints may be required until the source chromosome is identified. In the present series, 6 of the 12 cases were subjected to multiple WCPs and locus-specific probes by the referring institutions before being sent to our laboratory for CGH analysis. The identification of additional undefinable c+ogenetic material can also be achieved using other molecular cytogenetic techniques like reverse FISH-and multicolor FISH (spectral karyotyping and M-FISH)?, lo Although the information derived using reverse FISH is highly informative, the procedure is technically demanding and requires specialized micromanipulation equipment to microdissect and prepare probes from the region of interest. CGH is an alternative technique that can characterize unbalanced, unrecognizable G-banded cytogenetic material in a one-step global screening procedure. The advantage of CGH over multicolor FISH is its ability to identify not only the chromosome from which the additional unknown material was derived but to map the region involved to specific bands on the source chromosome. Although multicolor FISH would be able to identify intrachromosomal duplications such as those in cases 11 and 12, it would not be possible to characterize the involved regions with the same resolution obtained by CGH. Multicolor FISH has proven to be a powerful tool in the cytogenetic analysis of solid tumors. However, its success depends on the presence and to some extent the quality of metaphase spreads. This requirement limits its usefulness in cancer research and clinical cytogenetics where the lack of metaphases is quite common in certain solid tissue samples such as tumors and abortus material.
In the past, DA-DAPI staining has proved effective in idenbfjmg extrachromosomal material derived from proximal chromosome 15. Because 80% of markers originate from acrocentric chromosomes and half of these are derived from chromosome 15:s 27 the sole use of DA-DAPI staining to characterize the marker derived from chromosome 1 in case 5 may have led to the mistaken conclusion that it was derived from chromosome 15. This is because DA-DAPI staining highl~ghts the heterochromatic regions of chromosomes 1,9, 16, and Yqh in addition to 15pll (see Fig. 1: 1C and 2C) . Chromosome 15 markers have been characterized e x t e n~i v e l f~~~ and isochromosome 18p markers have also been well d o c u~n e n t e d .~~~~"~ Chromosome 1 markers are certainly rare but their presence may be under-reported especially in the premolecular era when DA-DAPI staining, in the absence of additional staining such as C-banding or NOR-banding, may have led to the labeling of such markers as being derived from chromosome 15. The number of reported clinical cases involving chromosome 1 markers is limited to 7, as summarized recently by C r~l l a .~~ To date, more than 180 articles have been published on CGH with the majority (approximately 80%) reporting the utility of CGH in the delineation of cytogenetic changes in more than 1500 tumor^.'^ The remaining CGH papers have dealt primarily with technical aspects and only a few have described the application of CGH in clinical c y t~g e n e t i c s . '~~~ CGH analysis software is now readily available as an optional addition to many FISH imaging systems and does not require additional specialized equipment. With many comprehensive cytogenetic laboratories now acquiring image analysis equipment for routine cytogehetic and FISH analysis, the use of CGH as a tool in clinical cytogenetics is likely to increase. In addition to being able to identify excess and/or missing chromosomal material not resolvable by G-banding, CGH could also be used as a backup method for aneuploidy analysis of specimens that have failed to grow in cell culture. This would be particularly useful in the analysis of nonviable fetal tissue derived from products of conception that is estimated to have a chromosome abnormality (mainly aneuploidy) approximately 50% of the time. 2 The sensitivity of CGH is an issue that has received much attention and, to date, no intensive and comprehensive study has been undertaken to accurately establish the minimum size of chromosome imbalance that CGH can detect. The theoretical detection limit of deletions by CGH has been estimated to be about 2 Mb.37 Bentz et al.38 recently reported 10 to 12 Mb to be the minimal size of deletions that CGH could detect. Their study samples, however, consisted of only five cases which were all mosaic for 1 l q deletions. Whether the sensitivity would have improved if the samples were nonmosaic was not addressed by those researchers. The technique of CGH is itself quite demanding and certainly requires considerable experience to obtain optimal results. Ghaffari et al.22recently used a modified CGH analysis strategy for identifying cryptic telomeric translocations in patients with idiopathic mental retardation. They were able to identify deletions and duplication as small as 4 Mb and 5 Mb, respectively. In contrast, Griffin et al. 21 were unable to use regular CGH to determine the origin of intrachromosomal duplications that were less than 10 Mb. They achieved increased CGH resolution by performing chromasome-specific CGH that combines flow sorting of chromosomes, degenerate oligonucleotide primed (DOP)-PCR, and a modified CGH technique. We were recently able to identify an intrachromosomal duplication in the range of 7 Mb (data not included in this study) using a standard CGH protocol. Whole chromosome aneuploidy clearly is within the detection limits of CGH. The ability of CGH to detect partial aneuploidy in the form bf marker chromosomes, unbalanced translocations, and intrachromosomal duplications is demonstrated effectively in this communication. CGH easily identified the additional material on all chromosomes in question in this report. In the unbalanced translocation cases in which the reciprocal monosomic regions were not evident in the CGH ratio profiles, the breakpoints could be designated from the GTG image as the terminal band of the derivative chromosome.
In conclusion, the use of CGH is rapidly being expanded in a clinical cytogenetic setting. As technical advances improve the capabilities of CGH, future additional applications are likely to include screening for deletions as small as those observed in the Prader-Willi and DiGeorge microdeletion syndromes. This will be made possible by the recent development of a matrix CGH protocol that combines biochip and CGH technologie~.'~ Using regular CGH would still remain an amactive and powerful accessory to routine clinical cytogenetic analysis.
